A MERTK LIGAND FOR ADOPTIVE T CELL CANCER THERAPY

摘要

The present invention relates to a method for improving the clinical efficacy of adoptive T cell therapy with a MerTK ligand. The invention further relates to a MerTK ligand for use in the treatment of a cancer in an individual, wherein said method comprises 5 adoptive T cell therapy.